Alopecia Areata DepressionAA_DEPNCT07711574
Prevalence of Depression Among Patients With Alopecia Areata
An observational study of Alopecia Areata Depression and Depression, run by Sohag University at 1 site in Egypt.
Trial summary
This study aims to assess how common depression is among patients with alopecia areata at Sohag University Hospital using a questionnaire. It is an observational study with no treatment involved. Read more about this study
- Who is it for?
- Ages 18 to 100 years
- Conditions the study is for
- Alopecia Areata Depression, Depression
- What is being tested?
- Observation only
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Sep 2027to 1 Apr 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with clinically diagnosed alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. The study population includes adult patients aged 18 years and above who are willing to participate in the study.
Who may be able to join
- Patients diagnosed with alopecia areata Age 18 years and above Attending dermatology outpatient clinic at Sohag University Hospital Willing to participate and provide informed consent
Who cannot join
- Patients with other causes of hair loss Patients with known psychiatric disorders prior to alopecia areata diagnosis Patients refusing participation
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site
Sohag university hospital
Sohag
Omima Atef, MD, 01098970741, omimaatef64@gmail.com
omimaatef64@gmail.com
About this study
Official title: Assessment of the Prevalence and Severity of Depression Among Patients With Alopecia Areata Attending Dermatology Clinics: A Cross-Sectional Study
This study aims to assess how common depression is among patients with alopecia areata at Sohag University Hospital using a questionnaire. It is an observational study with no treatment involved.
Read the detailed description
This is a cross-sectional observational study designed to evaluate the prevalence of depression among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Alopecia areata is an autoimmune condition characterized by non-scarring hair loss and may be associated with psychological distress.
The study will include patients diagnosed clinically with alopecia areata. Data will be collected through structured interviews and the use of a validated depression screening questionnaire. No therapeutic intervention will be applied during the study.
The aim of the study is to assess the psychological burden of alopecia areata and identify the frequency of depressive symptoms among affected patients. The findings may help in improving holistic patient care by addressing both dermatological and psychological aspects of the disease.
- Conditions
- Alopecia Areata Depression, Depression
- Being tested
- Observation only
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Observation onlyOther
This is an observational cross-sectional study with no therapeutic or experimental intervention. Data will be collected using a structured questionnaire to assess depression among patients with alopecia areata.
| Study group | Role | What they receive |
|---|---|---|
| Alopecia areata patients | Patients diagnosed with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. This is an observational cross-sectional study with no interventions. Data will be collected using a structured questionnaire to assess depressive symptoms. Receives: Other: Observation only |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of depression among patients with alopecia areata
The primary outcome is to assess the prevalence of depressive symptoms among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Depression will be evaluated using a structured validated questionnaire.
Measured: At enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2026
- Study start1 Sep 2027 (estimated)
- Primary completion1 Mar 2028 (estimated)
- Study completion1 Apr 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alopecia Areata DepressionStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Omima Atef Ahmed Mahmoud, Sohag University
- Investigators
- Omima Atef, MD, Principal investigator, ? Faculty of Medicine, Sohag University, EgyptOmima Atef, Principal investigator, ? Faculty of Medicine, Sohag University, Egypt
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07711574
- Sponsor's protocol ID
- AA _ Dep_ Omima _ sohag _2026
- Acronym
- AA_DEP
- Status last verified
- Jul 2026
- First submitted
- 5 May 2026
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared due to patient confidentiality and ethical considerations. The data collected in this study will be used solely for the purposes of the current research analysis and will not be made publicly available. Aggregated results may be published in scientific journals.
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of the Prevalence and Severity of Depression Among Patients With Alopecia Areata Attending Dermatology Clinics: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07711574
- Acronym / sponsor ID
- AA_DEP / AA _ Dep_ Omima _ sohag _2026
- Conditions
- Alopecia Areata Depression, Depression
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Sep 2027 (estimated)
- Primary completion
- 1 Mar 2028 (estimated)
- Study completion
- 1 Apr 2028 (estimated)
- First posted
- 17 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess how common depression is among patients with alopecia areata at Sohag University Hospital using a questionnaire. It is an observational study with no treatment involved.
Detailed description
This is a cross-sectional observational study designed to evaluate the prevalence of depression among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Alopecia areata is an autoimmune condition characterized by non-scarring hair loss and may be associated with psychological distress.
The study will include patients diagnosed clinically with alopecia areata. Data will be collected through structured interviews and the use of a validated depression screening questionnaire. No therapeutic intervention will be applied during the study.
The aim of the study is to assess the psychological burden of alopecia areata and identify the frequency of depressive symptoms among affected patients. The findings may help in improving holistic patient care by addressing both dermatological and psychological aspects of the disease.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Alopecia areata patients | – | Other: Observation onlyPatients diagnosed with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. This is an observational cross-sectional study with no interventions. Data will be collected using a structured questionnaire to assess depressive symptoms. |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with clinically diagnosed alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. The study population includes adult patients aged 18 years and above who are willing to participate in the study.
Key inclusion criteria (1 listed)
- Patients diagnosed with alopecia areata Age 18 years and above Attending dermatology outpatient clinic at Sohag University Hospital Willing to participate and provide informed consent
Key exclusion criteria (1 listed)
- Patients with other causes of hair loss Patients with known psychiatric disorders prior to alopecia areata diagnosis Patients refusing participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Observation onlyThis is an observational cross-sectional study with no therapeutic or experimental intervention. Data will be collected using a structured questionnaire to assess depression among patients with alopecia areata. | Other | Alopecia areata patients |
Primary outcome
Prevalence of depression among patients with alopecia areata
Time frame: At enrollment
The primary outcome is to assess the prevalence of depressive symptoms among patients with alopecia areata attending the dermatology outpatient clinic at Sohag University Hospital. Depression will be evaluated using a structured validated questionnaire.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared due to patient confidentiality and ethical considerations. The data collected in this study will be used solely for the purposes of the current research analysis and will not be made publicly available. Aggregated results may be published in scientific journals.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Omima Atef, MD principal investigator
? Faculty of Medicine, Sohag University, Egypt
Omima Atef principal investigator
? Faculty of Medicine, Sohag University, Egypt
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Alopecia Areata Depression and Depression, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Omima Atef, MD (01098970741, omimaatef64@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of depression among patients with alopecia areata (time frame: At enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.